Jan 7 (Reuters) - Novavax Inc NVAX.O :
* NOVAVAX - ON DEC. 31 2020, ENTERED AGREEMENT UNDER WHICH AUSTRALIA AGREED TO PURCHASE 51 MILLION DOSES OF NVX-COV2373
* NOVAVAX-WILL USE COMMERCIALLY REASONABLE EFFORTS TO OBTAIN REGULATORY APPROVAL FOR COVID-19 VACCINE FROM THERAPEUTIC GOODS ADMINISTRATION IN AUSTRALIA
* NOVAVAX INC - COMMONWEALTH OF AUSTRALIA MAY MAKE, FROM TIME TO TIME, ORDERS FOR UP TO A MAXIMUM AGGREGATE ADDITIONAL 10 MILLION DOSES OF NVX-COV2373
* NOVAVAX INC - COMMONWEALTH OF AUSTRALIA WILL REASONABLY SUPPORT CO WITH OBTAINING SUCH REGULATORY APPROVAL FOR COVID-19 VACCINE